Cause of failure after late-course accelerated hyperfractionated radiotherapy

沈春英,何少琴,环素兰,何霞云,潘自强,傅慈禧

DOI: https://doi.org/10.3760/j.issn:1004-4221.2003.03.002

2003-01-01

Abstract:Objective To evaluate the factors that predict locoregional failure and distant metastasis after late-course accelerated hyperfractionated radiotherapy (LCAHR) for nasopharyngeal carcinoma (NPC). Methods From December 1995 to March 1998, 178 patients with untreated but diagnosed histologically as poorly differentiated squamous cell carcinoma of nasopharynx were treated by LCAHR. The radiation schedule was as follows: 1.2 Gy/Fx, twice daily, 5 days per week for four weeks, followed by 1.5 Gy, twice daily , 5 days a week in the concluding two weeks, to a total dose of 78 Gy/60Fx/6w. Patients were given additional 1.2 or 1.5 Gy x 2Fx for one day if the treatment time lasted beyond 47 days. Patients without lymph node metastasis were only given radiotherapy prophylactically to the neck only, while radical treatment was delivered to node positive groups. Results The 5-year overall survival and disease-free survival rates were 72.4% and 60.6% . The 5-year distant metastasis rate was 25.1 % . 38% (67/178) of patients developed recurrent disease: 10 at the primary site, 13 in the neck region, 31 at distant site and 13 both in the head-and-neck and distant site. Both univariate and multivariate analyses revealed that T3-T4, older than 50 years and invasion of total cervical arterial area were poor prognostic factors for the primary control. In univariate analysis, positive node was found as an adverse factor that predicted prognosis in cervical control, but the difference was not significant in the multivariate analysis. Local advanced stage (T3-T4 or N2-N3) and being male were significantly associated with high distant metastasis, in both univariate and multivariate analyses. Conclusions LCAHR can improve the 5-year primary control rate and survival rate for NPC. Patients with T3-T4 or N2-N3 disease give poor prognosis. In our study, distant metastasis ,being high, is the common cause of death in NPC. Aggressive treatment may benefit this group of patients.